⚠ For research purposes only — not for human consumption. Not evaluated by the FDA.
5mg
AOD-9604 is a modified fragment of human growth hormone (hGH), specifically the 191 amino acid sequence from positions 177–191. This fragment has been studied for its lipolytic (fat-breaking) effects without the other growth properties of full hGH. It has been researched for obesity, metabolic syndrome, and cartilage repair.
Research protocols typically use 250–500 mcg daily, administered via subcutaneous injection. The peptide can be taken once daily and is often studied in the context of diet and exercise programs. AOD-9604 is stable and can be reconstituted with bacteriostatic water for research purposes.
⚠ This information is from published scientific literature and is provided strictly for research reference. Not for human use. Follow all applicable laws and institutional protocols.
AOD-9604 works by mimicking the fat-reducing effects of growth hormone while avoiding the growth-promoting effects. It activates fat metabolism through a mechanism that appears distinct from standard beta-3 adrenergic stimulation. Research has demonstrated results in reducing adipose tissue accumulation in animal models, with human studies showing promise for waist circumference reduction. The peptide is FDA-approved for veterinary use in horses and continues to be studied for human applications.
Bacteriostatic water is required to reconstitute lyophilized peptides for research applications.